Description
|
RC 206-2
15 min
|
A. Morphological response assessment: RECIST 1.1
Melvin D'Anastasi, Msida / Malta
|
| 1. To understand the basic concepts of morphological therapy monitoring. 2. To understand how RECIST 1.1 has simplified the previous criteria (RECIST 1.0). 3. To understand the limitations of morphological therapy monitoring. |
|
|
RC 206-3
15 min
|
B. Molecular response assessment: from EORTC to PERCIST
Helmut Prosch, Vienna / Austria
|
|
1. To understand the basic concepts of molecular therapy monitoring.
2. To understand the limitations of molecular therapy monitoring. 3. To learn of non-FDG tracer applications for therapy monitoring. |
|
|
RC 206-4
15 min
|
C. Monitoring immune-therapy: iRECIST and iPERCIST
Egesta Lopci, Rozzano / Italy
|
|
1. To understand the basic concepts of morphological therapy monitoring of immune therapies.
2. To understand the differences between various response criteria. 3. To understand the limitations of the various response criteria. |
|
|
10 min
|
Live Q&A: Implications for clinical workflows
|
